Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based studyTrine Trab, Kirsten Grønbæk, Michael Roost Clausen et al.|Blood Neoplasia|2025Cited by 4
Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in DenmarkTrine Trab, Kirsten Grønbæk, Iman Chanchiri et al.|Blood|2024Cited by 0
Secondary central nervous system lymphoma (<scp>SCNSL</scp>) in mantle cell lymphoma (<scp>MCL</scp>): Characteristics and risk factors in a Danish nationwide population‐based studyTrine Trab, Kirsten Grønbæk, Torgerð Ranadóttir et al.|British Journal of Haematology|2025Cited by 0